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Abstract 
[2-~3C]glycine metabolism was studied in freshly isolated rat renal proximal tubules. Mitochondrial coupling of the glycine cleavage 
complex (GC) and serine hydroxymethyltransferase (SHMT) was confirmed by the formation of three serine isotopomers, [2-13C]-, 
[3-13C] - and [2,3-]3C]serine, detected by 13C-NMR. Incubation with different fractions of 13C-labelled glycine altered the labelling 
pattern of the serine isotopomers predictably and allowed calculation of the ]3C-labelled fractions of total glycine and methylene in 
NS, Nl°-methylenetetrahydrofolate (m-THF) available for serine metabolism. Within 20 min there was a fall in labelled glycine (to 
42 _ 3, 68 + 3 and 93 ___ 2%, (n = 4, mean _ S.D.) from 50%, 75% and 100% ]3C-labelled added glycine respectively), followed by a 
slow rate of endogenous glycine formation for up to 80 min incubation. The C2 of glycine was the source of more than 90% of the 
methylene group of m-THF formed. Gas chromatography-mass spectroscopy (GC-MS) showed that greater than 50% of serine formed 
was unlabelled. GC and SHMT proceeded in the direction of serine formation. Serine isotopomer analysis by NMR and GC-MS allowed 
the actions of GC and SHMT and de novo contributions to glycine, serine and m-THF to be monitored in situ in fresh renal proximal 
tubules. 
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1. Introduction 
Recent observations that glycine, and to a lesser extent 
alanine, protect isolated renal proximal tubules, cultured 
renal cells and possibly the intact kidney against hypoxic 
and toxic injury [1-7] have stimulated interest in glycine 
metabolism. The two principle enzymes involved in glycine 
and serine interconversion are serine hydroxymethyltrans- 
ferase (SHMT, EC 2.1.2.1) and glycine cleavage complex 
(GC, EC 2.1.2.10). Studies of these enzymes in liver 
suggest hat SHMT catalyses the breakdown of serine and 
that glycine catabolism occurs via GC [8]. These reactions 
maintain the one-carbon pool, essential in many cellular 
synthetic pathways. The combination of these reactions in 
the reverse direction allows the synthesis of serine from 
two molecules of glycine: 
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Scheme 1 
Serine is released into the circulation by the kidney, 
indicating net renal serine formation. Renal arteriovenous 
differences have demonstrated that glycine is quantita- 
tively important as a serine precursor [9], suggesting serine 
formation by GC and SHMT in the kidney. Detailed 
investigation of glycine-serine interconversion has been 
made in freshly isolated renal proximal tubules. While 
SHMT is present in both mitochondria nd cytosol, GC 
activity is restricted to the mitochondria [10,11]. The inner 
mitochondrial membrane is impermeable to reduced folate 
coenzymes [12,13], therefore serine formation via SHMT 
utilising m-THF formed from glycine must be exclusive to 
mitochondria. Investigations of purified liver SHMT have 
shown differences between cytosolic and mitochondrial 
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SHMT, including greater affinity for glycine in the mito- 
chondrial enzyme [14] and dependence of kinetic parame- 
ters on the number of glutamates bound to m-THF [15]. 
These studies suggest similar rates for the forward and 
reverse reactions of SHMT. Investigations of [2- 
14C]glycine metabolism in rat kidney cortical slices 
demonstrated that the ratio of glycine utilisation:serine 
formation:ammonium formation:14 CO 2 liberation is 2:1:1:1 
[16]. Therefore, m-THF formed from glycine is utilised by 
SHMT and is not oxidised further [10,14,15], suggesting 
tight coupling of GC and SHMT reactions. 
The presence of both GC and SHMT enzymes in a 
tissue should lead to the formation of [2-~3C]serine, [3- 
13C]serine and [2,3-13C]serine from [2-13C]glycine which 
can be detected as unique peaks by ~3C-NMR. This is not 
easily achieved using GC-MS, which cannot differentiate 
between [2-13C] - and [3-13C]serine, or by 14C-studies 
which would require isolation of each carbon within ser- 
inc. These three serine ise,topomers were recently detected 
in Saccharomyces cerevisiae by 13C-NMR [17]. However, 
the single 13C-NMR study of [2-~3C]glycine metabolism 
by renal cells, that of cultured LLC-PKJC14 cells [18], 
reported only [2-13C]serine formation, which suggests that 
the GC was absent. In this study we examined serine 
formation from [2-~3 C]glycine in freshly isolated rat renal 
cortical tubules and present a novel method of determining 
the fraction of ¿3C-labelled glycine and m-THF available 
for serine metabolism for comparison with the fraction of 
13C-labelled glycine in the total sample as measured by 
GC-MS. The fraction of raethyl groups in m-THF derived 
from glycine could also be calculated. Comparison of 
serine isotopomer analysis and GC-MS should allow the 
relative rates of the forward and reverse direction of 
SHMT and GC and de novo formation of glycine and 
serine to be estimated in intact proximal tubules. 
2. Experimental 
2.1. Proximal tubule isolation 
Male Wistar rats, weighing 400-550 g, with free access 
to water and fed ad libitum with rat and mouse cubes 
(NORCO, Lismore, NSW, Australia), were used in all 
experiments. The rats were anaesthetised with pentobarbi- 
tone sodium (60 mg/kg i.p.). The abdominal aorta was 
exposed to allow antegrade perfusion of the kidneys with 
50 ml of solution A (calcium-free Hanks' balanced salt 
solution buffered with Hepes and containing 5 mM glu- 
cose, 4 mM lactate and 1 mM alanine). The kidneys were 
decapsulated, removed and placed in solution A on ice. 
Cortical tubules were then isolated by a modification of 
the method of Vinay et al. [19]. While keeping the kidney 
cold, the cortex was dissected off, weighed, finely minced, 
then digested for 50 min in 1.5 mg/ml collagenase (Sigma 
type II) in solution B (solution A supplemented with 0.1 
mM CaC12 and 2.5% BSA, Pentex, fraction V, Miles 
Laboratory, California, USA) at 37°C under 
95%O2/5%CO 2 in a hooded shaking water bath. The 
digested tissue was filtered, washed twice with cold solu- 
tion B then resuspended in 35% Percoll (Pharmacia, Upp- 
sala, Sweden) in Krebs Henseleit saline (KHS) containing 
5 mM glucose, 4 mM lactate and 1 mM alanine and 
centrifuged at 30000 × g for 30 min at 4°C. Proximal 
tubule segments were harvested from the thick bands near 
the bottom of the tube. A sample of freshly isolated 
tubules was kept for assay of hexokinase [20], phospho- 
enolpyruvate carboxykinase [21] and for microscopic ex- 
amination. Prior to incubation with 13C-substrates, tubules 
were washed sequentially at 4°C with solution B, with 
KHS and with the incubation medium (one wash each). 
2.2. Experimental protocol 
Incubation was commenced by adding tubules, 1.5 to 2 
ml loosely packed tubules (cytocrit ~ 30%, 225-270 mg 
protein) to the incubation medium in a screw top conical 
flask, top gassed with 95%O2/5%CO 2 (O2/CO 2) at 2 
1/min for 4 min in a shaking water bath at 37°C and 
sealed. The flask was regassed following addition or re- 
moval of samples. For sequential studies, purified proxi- 
mal tubules were added to 40 ml KHS containing 5 mM 
glycine containing 75% ~3C-labelled [2-13C]glycine 
(C /D/N  Isotopes, Quebec, Canada). A 5-ml sample was 
taken immediately (0 min) and at 5, 10, 20, 40 and 80 min. 
The samples were snap-frozen i  liquid N 2 and stored at 
-70°C. For studies comparing the effect of incubation 
with variable fractions of ~3C-labelled glycine, tubules 
were added to 15 ml KHS containing 5 or 10 mM glycine, 
either as 100%, 75%, or 50% 13C-labelled [2-13 C]glycine 
with [2-12 C]glycine making up the balance. The tubules 
were then incubated for 20 min at 37°C. Following incuba- 
tion, the sample was centrifuged, and the supernatant and 
pellet were snap-frozen i liquid N 2 and stored at -70°C. 
Samples were extracted with perchloric acid (PCA) for 
13C-NMR analysis as described below. 
14C-Inulin (0.15 /zCi, Amersham International, Amer- 
sham, UK) was added 10 min before the end of all 
incubations for estimation of the fraction of extracellular 
water, from which sample wet weight could then be calcu- 
lated. Samples were taken at the completion of incubation 
for assay of protein, ~4C-inulin and LDH. 
2.3. Tubule integrity 
Tubule cell integrity was assessed by measuring the 
release of lactate dehydrogenase (LDH) into the incubation 
medium. LDH was assayed after Bergmeyer et al. [22] and 
expressed as the percent of activity in the supernatant 
relative to the total sample following addition of Triton 
X-100. The fraction of viable cells was assumed to equal 
(100 - %LDH released)/100. 
34 G.J. Cowin et al. / Biochimica et Biophysica Acta 1310 (1996) 32-40 
2.4. Protein determination 
Protein was measured by a modification [23] of the 
method of Lowry [24]. BSA was used as the protein 
standard. 
2.5. Sample extraction 
Samples were weighed and placed on ice. Two volumes 
of 12% PCA were added to the samples, which were then 
homogenised by three 3-s bursts of an IKA homogeniser 
(type 25, Janke and Kunkel, Staufen, Germany). The sam- 
ples were centrifuged at 4°C and the supernatant stored on 
ice. The pellet remaining from each sample was extracted 
a second time with PCA. Following centrifugation, both 
supernatant samples for each experiment were pooled, 
neutralised using 3 M KOH, centrifuged, then freeze-dried 
and stored at -20°C. Samples were kept at 4°C through- 
out the extraction. 
2.6. NMR sample preparation 
One ml D20 (99.9 atom% D, Sigma Chemicals, St. 
Louis, USA) and 4 ml H20 were added to each lyophilised 
sample and the pH adjusted to 7.0 with KOH. The sample 
was then stored at 4°C until analysis. Immediately prior to 
the NMR. measurement, 3 ml of the supernatant was 
transferred to a 10 mm NMR tube and 150 /zl of 1.8 M 
tetramethylsilylpropanoic acid (TSP, MSD Isotopes, Mon- 
treal, Canada) was added to a final concentration f 85.7 
mM. Ethylenediaminetetra-acetic acid (EDTA, 1 mg) was 
added to each sample. 13C-NMR spectra were acquired 
using a Bruker AMX500 spectrometer. Standard ata ac- 
quisition parameters for partially relaxed spectra used were: 
frequency 125.77 MHz; temperature 303°K, repetition in- 
terval 2 s (acquisition time 0.49 s; recycle delay 1.5 s, 7/xs 
pulse length). The WALTZ sequence was used for proton 
decoupling [25]. 
2.7. Isotopomer analysis 
When the incubation medium contains both [2- 
13C]glycine and unlabelled glycine (i.e., [2-12 C]glycine), 
four isotopomers of serine should be formed by the follow- 
ing reactions: 
[2 -13C]glycine + [IaC]m-THF [2,3 -'3C]serine 
(1) 
[2 -'3C]glycine + m-THF ~ [2 - '3C]serine (2) 
glycine + [13C]m-THF ~ [3 - '3C]serine (3) 
glycine + m-THF ~- serine. (4) 
The ratio of the reaction products of Eqs. (1) and (3) are 
independent of the fraction of labelled m-THF and may be 
written as: 
[2,3 - 13 C] serine/[3 - 13  C] serine 
= [2 - 13 C ] glycine/glycine, (5) 
so that the fraction of glycine which is [2-13C]-labelled 
(Fgly) is given by [26]: 
Fe, ~. = [2,3 -13C]serine/([2,3 --'3C]serine 
+ [3 --13C]serine). (6) 
Reactions 1 and 2 are similarly dependent on the 13C- 
labelled m-THF ratio and independent of the labelled 
glycine ratio. Therefore the fraction of labelled m-THF 
(F m) can be obtained from: 
[2,3 - '3C]ser ine/[2 -13C]serine 
= 13C - m-THF/m-THF, (7) 
hence 
F m = [2,3 -13C]serine/([2,3 -13C]serine 
+ [2 -13C]serine). (8) 
If m-THF is derived exclusively from glycine, the 
percentage of labelled m-THF will equal the fraction of the 
labelled glycine. We can determine the percentage of 
m-THF formed from glycine (Frn(GC)) by: 
Fm(GC )= Fm/Fx,y (9) 
2.8. NMR quantitation 
Peak assignment was based on published ata, spectra 
of aqueous tandards acquired under similar conditions and 
by superposition of peaks in experimental samples of 
proximal tubule extracts. The FID was Fourier-transformed 
with 2 Hz line broadening. The Bruker deconvolution 
package with 100% Lorentzian line shape simulation was 
used to determine peak integrals. The only case in which 
the deconvolution package had difficulty simulating peaks 
was for the serine singlets in the 100% labelled glycine 
experiments. Unlabelled glycine is required for singly 
/3C-labelled serine formation. Since no exogenous unla- 
belled glycine was added, only very small amounts of 
singly 13C-labelled serine were formed. The line width, 
and hence integral, assigned to these singlet peaks was 
much greater than the standard 13C peak line width, as a 
consequence of low signal-to-noise (S/N) and the overlap- 
ping shoulders of the doublet peaks (Fig. 3). Independent 
investigation of this effect suggested that peaks with S/N 
levels below 10, start to demonstrate his effect (data not 
shown). Since both the singlet and doublet are formed 
from the same carbon, similar line widths are expected. 
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Peak intensities were standardised to allow for this varia- 
tion by dividing the integral of each peak by its own line 
width. When peak quantitation was required, uncorrected 
peak integrals were used, except he singlet peaks in the 
100% labelled glycine experiments were divided by their 
line width and then multiplied by the average line width of 
the carbon doublet peaks. 
For determination of Fgly, [2,3-13C]serine was deter- 
mined from the sum of the intensities of the C3-serine 
doublet peaks and [3-13C]:serine from the C3-serine singlet 
peak. For determination of Fro, [2,3-13C]serine was esti- 
mated from the sum of the C2-serine doublet peaks and 
[2-13 C]serine as the C2-serine singlet peak. Since only 
singlets and doublets from the same carbon were com- 
pared, correction for T 1 and nOe differences between 
carbons was not required. Bonded ~3C atoms introduce an 
additional dipole relaxation mechanism with the potential 
to influence the T 1 of the carbon atoms and hence the 
nuclear Overhauser enhancement potentially introducing 
quantitation errors. However, previous investigations of 
this effect have demonstrated that the 13C-13C dipole 
contribution to the nuclear Overhauser enhancement for 
carbons with bonded protons (as in the 2- and 3-position 
of serine) is less than 1% [27]. However, when carbon 
atoms are not protonated, e.g., carboxylic acid groups, the 
contribution may be 25-30% [27]. Hence, previous 
metabolic studies utilising isotopomer analysis only derive 
results from protonated carbons, e.g., the 2, 3 and 4-posi- 
tions of glutamate but not position 1 or 5 [28]. Similarly, 
the relative intensities of multiplets derived from proto- 
nated carbons in the 2- and 3-position of serine in our 
experiments are not significantly influenced by 13C-13C 
dipole interaction. 
Glycine and serine concentrations were estimated from 
their peak intensities relative to TSP which was in turn 
calibrated against standard curves using PCA-extracted 
samples with known glycine and serine concentrations 
measured under identical conditions. Separate calibration 
curves were used for [2-13C], [3-13C]serine and [2- 
~3C]glycine. For [2,3-13C]serine the 2- and 3-position dou- 
blets were calibrated against he 2- and 3-position singlet 
curves. Since one molecule of [2,3-13C]serine contains two 
atoms of ~3C, the average of the doublet concentrations 
represents the amount of serine which is doubly 13C- 
labelled. The sum of the doublet concentrations represents 
the total amount of 13C incorporated into [2,3-13C]serine. 
Summarising, the amount of 13C-labelled serine formed 
was taken as the sum of the concentrations of [2-13 C]serine, 
[3-13C]serine plus the average of the 2-carbon and 3-carbon 
doublets. Total incorporation of 13C-label into serine (for 
comparison with the decrease in [2-13C]glycine) was deter- 
mined from the sum of the concentrations from [2- 
13C]serine, [3-13C]serine plus both serine doublets. During 
a 20-min incubation serine formation was expressed as 
/zmol.g wet wt -1 and /zmol.g protein -1. Rates from 
sequential studies were determined as /xmol • g protein-1 
per h for two time periods, 0-5 min and 20-80 min. When 
monitoring time-dependent changes, peak intensities were 
corrected for cell viability by dividing the change in 
intensity between time points by the average cell viability 
at these points and then adding the quotient o the peak 
intensity of the first of the two time points. 
2.9. GC-MS analysis of ~3C enrichment of serine 
Serine and glycine 13C enrichment was performed using 
a Hewlett-Packard 5840 gas chromatography unit using a 
DB-1 bonded phase capillary column and a Hewlett- 
Packard 5985B mass spectrometry s stem operating in the 
selected-ion-monitoring data acquisition mode. Samples 
were prepared as follows, a 1:1 slurry of cation exchange 
resin (Dowex AG50 X 8; 200-400 mesh, Bio-Rad Labora- 
tories, Hercules, CA) and deionised water was added to a 
disposable column to provide a 2-cm resin bed. The resin 
was washed twice with 5 ml of deionised water and kept 
moist. The NMR sample (0.5 ml) was acidified with 0.1 M 
HC1 to pH 2 and added to the resin bed. The column was 
washed with 2 X 5 ml of deionised water and the eluant 
discarded. The amino acids were eluted with 2 × 1 ml of 3 
M NHaOH. The eluant was collected and dried. Tertiary- 
butyldimethylsilyl-derivatives of the amino acids were pre- 
pared by adding N-methyl-N-(tertbutyldimethylsilyl)-tri- 
fluoroacetamide:acetonitrile (1:1, both compounds from 
Pierce, Rockford, IL) to the dried residue and heating to 
100°C for 2 h. Ions of mass 246.1 and 247.1 were moni- 
tored for glycine and ions of mass 390.2, 391.2 and 392.2 
were monitored for serine. 
2.10. Statistical methods 
Results are expressed as mean ___ S.D., statistical differ- 
ences between points within an experiment were deter- 
mined using a paired Student t-test, while differences 
between different experiments were determined using an 
unpaired Student -test. 
3. Results 
3.1. Proximal tubule purity and integrity 
By microscopy, 95% of purified cortical tubules were 
short lengths of proximal tubules, while the remainder 
were principally segments of the thick ascending limb of 
the loop of Henle. The specific activity of phospho- 
enolpyruvate carboxykinase was 37.3 + 8.0 /zmol. min -1 
per g protein (mean ___ S.D., n = 10), and the activity of 
hexokinase, 27.8 + 4.6 /zmol • min -1 per g protein (n = 
10), confirming that the tubules were primarily of proximal 
origin. The average LDH released into the medium with 
time for tubules incubated in 5 mM glycine is shown in 
Table 1. LDH release into the medium at 20 min for 
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Table 1 
Tubule viability and Ugly following incubation with 5 mM 75% [2- 
] 3 C]glycine 
Incubation time (min) 0 5 10 20 40 80 
% LDH release 4.7 5.3 5.3 6.8 12 30 
~ - - F_ly (%) 68.8 67.9 67.8 66.8 65.8 
Dependence of tissue viability, expressed as percent of LDH released into 
the medium, on incubation time. 
The fraction of 13C-labelled glycine was also calculated for each time 
point (n = 2). 
tubules incubated with different fractions of 5 mM labelled 
glycine was 7.7 + 1.5% (n = 12), which is similar to 
values reported for incubation of proximal tubules with 
other substrates in addition to glycine [1]. 
3.2. Incubation of proximal tubules with [2-/~C]glycine 
A typical 13C-NMR spectrum from proximal tubules 
incubated in 5 mM [2-13C]glycine for 20 min is shown in 
Fig. 1. The spectrum shows the incorporation of the laC- 
label from [2-13C]glycine (42.8 ppm) into the three iso- 
topomers of serine: the [2-taC]serine singlet at 57.7 ppm; 
the [3-13 C]serine singlet at 61.5 ppm and the [2,3-13 C]serine 
with doublet peaks at 57.6 and 57.8 ppm for C2-serine and 
at 61.4 and 61.6 ppm for C3-serine. The intense peak at 
-1 .7  ppm and multiplets at 13 and 32 ppm are from the 
TSP reference. Small peaks at 45.9 ppm and 62.1 ppm 
were often observed but remain unassigned. 
The sequential incorporation of 13C-label from [2- 
13C]glycine into serine is shown in Fig. 2. Peak intensities 
were averaged from two experiments, each corrected for 
sample weight, protein content and the percentage of vi- 
able cells estimated from the LDH release into the medium. 
The fraction of 13C-labelled glycine (Ugly) determined  by 
ser lne  
Prox imal  Tubules 
20min  Incubat ion  
5mM 12-13C]glycine 
. /  
, i • • 
ppm 60 50 40 3'0 20 1'0 0 
Fig. 1. ~3C-NMR spectrum of glycine metabolism by renal proximal 
tubules. Purified proximal tubules were incubated with 5 mM [2- 
~3C]glycine for 20 min. Samples were extracted with perchloric acid, 
freeze-dried then reconstituted with 20% D20 in H20 for ~3C NMR 
acquisition. ( * )sodium 3-(trimetbylsilyl) propionate-2,2,3,3-D 4 reference. 
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Fig. 2. Time-dependent incorporation of ]3C-label from glycine into 
serine. [2-13C]glycine (©), 13C-label incorporated into serine (• )  and the 
sum of t3C label in glycine and serine (0 )  were determined uring 
incubation of proximal tubules with 5 mM 75% 13C-labelled glycine 
(n = 2). The peak intensities of glycine and serine at each time point were 
corrected for sample weight and protein content. The formation rates of 
]3C-labelled serine from 0-5 min and 20-80 min are 340 /zmol.g 
protein-] per h and 61 /zmol.g protein-I per h respectively. 
application of Eq. 6 to the serine isotopomers i  shown in 
Table 1. The decrease in the mean values of Ugly for  the 
two time series experiments was not significant over the 
80-min incubation period. No major metabolites of glycine 
other than serine were observed in the 13C-NMR spectrum 
(Fig. 1). This is supported by the constant sum of 13C-label 
in glycine and serine (Fig. 2). 
3.3. Varying the fraction of 13C-labelled glycine 
An incubation time of 20 min was chosen to ensure 
good cellular integrity and stable reaction conditions. Typi- 
cal spectra from tubules incubated in 10 mM glycine 
showing the relationship between the ratio of doubly and 
singly labelled serine and the fraction of initial labelled 
glycine added are shown in Fig. 3. Incubating proximal 
tubules with 100% [2-t3C]glycine formed mainly [2,3- 
13C]serine. As unlabelled glycine was added, reducing the 
fraction of 13C-labelled glycine to 75% or 50%, the sin- 
glets formed by [2-13 C]serine and [3-13C]serine predomi- 
nated over [2,3-13C]serine. The mean fraction (+ S.D.) of 
13C-labelled glycine (Ugly) calculated from the serine iso- 
topomers and that determined irectly by GC-MS for 
tubule samples incubated with 5 mM glycine in 4 separate 
experiments are shown in Table 2. There was no signifi- 
cant difference between the NMR and GC-MS results for 
each group. The reduction by 7-8% in the fraction of 
t3C-labelled glycine following 20 min incubation suggests 
formation of unlabelled glycine or dilution with pre-exist- 
ing unlabelled glycine. Estimates of the fraction of labelled 
m-THF are similar to although lower than the fraction of 
labelled glycine at 100% and 75% initial fraction of 13C- 




(61.5 ppm) (57.7 ppm) 
Fig. 3. Dependence s rine 13C-NMR doublets and singlets on initial 
fraction of lac-labelled glycine. Freshly isolated proximal tubules were 
incubated for 20 min with l0 mM glycine, which was either 100%, 75% 
or 50% lac-labelled. 
labelled glycine (Table 2). This is consistent with the high 
calculated fraction of m-THF derived from glycine via GC 
(Table 2), which indicates that the C2 of glycine is the 
major source of the methylene group in m-THF in this 
preparation. Ultimately this methylene becomes the C3 
carbon of serine via addition to a second glycine in the 
reaction catalysed by SHMT. 
The fraction of serine containing only ~2C carbon atoms, 
singly laC-labelled carbon atoms, and doubly lac- label led 
carbons determined from GC-MS are presented in Table 3. 
The fraction of unlabelled serine was consistently slightly 
greater than 50%, even in experiments where the only 
substrate added was 100% laC-labelled glycine. When the 
fraction of unlabelled glycine was increased to 50%, the 
fraction of unlabelled serine increased. The proportion of 
singly and doubly labelled serine determined by GC-MS 
Table 2 
Comparison of isotopomer analysis and GC-MS data 
Initial 13c_labelled glycine 
100% 75% 50% 
Glycine formation 
Ugly(13C-NIVIR) 93+2 68+3 a 425:3 a 
Glycine enrichment (GC-MS) 86 5:7 66 + 6 a 42 + 4 a 
m-THF Formation 
Fm(%) 87+3 b 64+2 ab 42+0.7 a 
Fm(GC)}(%) 94 + 3 95 + 2 99 5:7 
Estimates of taC-labelling of glycine determined from serine isotopomer 
anaysis (JaC-NMR) and from direct measurement (GC-MS) following 
incubation of proximal tubules with 13C-labelled and unlabelled glycine 
(n = 4, mean + S.D.). 
a Significant difference compared to previous column (P(0.05). 
b Significant difference compared to Ugly (P (0 .05) .  
Table 3 
Serine production and i3C-labelled distribution 
Initial 13 C-labelled glycine 
100% 75% 50% 
J3C-Serine formation 
/zmol • g wet wt- J 17 + 8 13 5:- 3 8.4 + 1.7 
/xmol. g protein -1 70+21 49-t-10 37+6 
Serine 13C_enrichment (%) 
Unlabelled 53 -I- 3 53 + 3 58.7 + 1 a 
Singly i3C-labelled 13___3 20.5±5 a 23+0.5 
Doubly 13 C-labelled 33.4 + 10.2 26.2 + 1.6 a 18 + 1 a 
Following 20 min incubation, serine formation determined from ~3C- 
NMR, while serine t3C-enrichment was determined by GC-MS (n = 4, 
mean + S.D.). 
a Significant difference compared toprevious column (P < 0.05). 
changed similarly to that determined by NMR with a 
decrease in doubly labelled serine and an increase in the 
singly labelled serine as the fraction of 13C-labelled glycine 
was decreased. Thus approx. 50% of serine formed in 
proximal tubules incubated with glycine as a single sub- 
strate was not derived from this glycine but from some 
other source or was already present at the start of incuba- 
tion. 
4. Discussion 
The combined action of GC and SHMT in freshly 
isolated proximal tubules was confirmed by the formation 
of [2-13 C]serine, [3-13C]serine and [2,3-13 C]serine from 
[2-t3C]glycine. Glycine metabolism effectively proceeded 
only to serine in this preparation of renal proximal tubules 
since other major peaks were not detected. This was 
supported by the time course of these reactions, in which 
the sum of 13C-label in glycine and serine remained con- 
stant over 80 min (Fig. 2). Previous investigations of rat 
kidney cortical slices have found no evidence of serine 
utilisation [16]. After 20 min the rate of serine formation in 
our studies became constant (Fig. 2) at 61 p~mol, g wet 
wt-~ per h (equivalent to 380 /xmol .g  dry wt-1 per h). 
This is much greater (allowing for differences in wet and 
dry weights) than previously reported for Percoll purified 
rat proximal tubules incubated with 5 mM glycine for 30 
min (62.6 + 11.4/xmol • g dry wt -  1 per h) [29]. 
In contrast to our studies in freshly isolated rat proximal 
tubules, cultured porcine proximal tubular cells (LLC- 
PK1/C14) incubated with 7 mM [2-~3C]glycine show nei- 
ther [3-13C]serine nor [2,3-13C]serine [18], suggesting that 
GC was absent or inactivated in this cultured cell line. An 
intense peak at 60.9 ppm in the PCA extract of LLC- 
PK 1/C14 cells was assigned to [2-13 C]L-threonine [ 18] and 
led to the suggestion that SHMT catalyses the formation of 
threonine from glycine and acetaldehyde. Addition of thre- 
onine to our experimental samples formed a new peak 
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(61.7 ppm) not present in the initial spectra nd partially 
overlapping the downfield 3-serine doublet, Reassigning 
the reported threonine peak at 60.9 ppm to [3-13C]serine 
does not confirm GC activity in LLC-PKI/C14 cells, since 
[3-13C]serine formation requires combined GC and SHMT 
activity, which would also form [2,3-13C]serine and this 
was not present in the spectrum. The LLC-PK1/C14 cells 
were also reported to form 13-hydroxybutyrate t 45.9 ppm 
[ 18], which suggests that glycine and serine are precursors 
for the glycolytic pathway. Possible pathways for conver- 
sion of serine to acetyl-CoA are the non-phosphorylated 
pathway (via serine aminotransferase, EC. 2.6.1.51) and 
serine dehydratase (EC. 4.2.1.13) which are essentially 
restricted to the liver [30]. Although we usually obtained a
small peak at 45.9 ppm, the addition of 13-hydroxybutyrate 
gave an independent peak at 47.3 ppm. Furthermore, we 
could not detect 6-hydroxybutyrate in samples analysed by 
high-performance liquid chromatography (data not shown). 
The small peak at 45.9 ppm remains unassigned. Our 
results from freshly isolated tubules uggest LLC-PKI/C14 
cells have dedifferentiated with respect to glycine 
metabolism in normal renal proximal tubules. Other 
metabolic alterations, including increased glycolytic activ- 
ity and decreased oxidative metabolism have been reported 
for primary renal proximal tubule cultures maintained in 
stationary culture [31 ]. 
These 13C-NMR studies allowed some assessment of 
compartmental equilibration of glycine and of the relative 
rates of glycine to serine versus serine to glycine reactions. 
The serine isotopomers are derived from the serine formed 
from glycine during the incubation. Therefore, the frac- 
tions of 13C-labelled intracellular glycine and m-THF 
utilised by GC and SHMT are predicted from these iso- 
topomers. GC-MS measures the average fraction of ~3C- 
labelled glycine in a whole sample, which includes both 
intracellular and extracellular glycine. Identical values of 
~3C-labelled glycine were determined by ~3C-NMR and 
GC-MS. This indicates that equilibration of intracellular 
and extracellular glycine must have occurred, otherwise 
the unlabelled glycine formed intracellularly would have 
reduced the intracellular fraction of 13C-labelled glycine 
available for serine formation. Therefore, Fg~y calculated 
from the serine isotopomers would have been lower than 
the fraction measured by GC-MS. Comparison of intra- 
cellular and extracellular glycine confirmed rapid transport 
of glycine into the proximal tubules giving a 4-fold higher 
concentration of intracellular glycine (data not shown) 
similar to previous investigations by Weinberg et al. [2]. 
In these freshly purified proximal tubules, serine forma- 
tion from glycine appears to be the preferred irection of 
SHMT and GC. Specific fractions for total 13C-labelled 
glycine and serine are maintained uring incubation. When 
glycine was 93%, 68% or 42% 13C-labelled (Table 2), 
serine was 46.4%, 46.7% and 41% 13C-labelled respec- 
tively (Table 3). If the forward and reverse reactions of GC 
and SHMT were rapid and equivalent, the fraction of 
labelled glycine and the total fraction of labelled serine 
would become equivalent. Clearly, the total fraction ~3C- 
label did not equilibrate between glycine and serine. In 
contrast to our renal tubule experiments, studies of purified 
liver SHMT indicate glycine formation from serine is the 
preferred irection of SHMT [15,32]. Two conditions used 
in this study should drive the reaction from glycine to 
serine. Firstly, the reaction has not reached equilibrium at 
20 min. Therefore a concentration f 5 mM glycine, which 
approximates the SHMT Kin for glycine in liver, should 
drive the reaction to serine, since the concentration of 
serine formed remains well below its Kin. Secondly, in the 
mitochondria the association of GC with SHMT should 
immediately scavenge THF formed by SHMT and convert 
it back to m-THF, continually driving the reaction towards 
serine. Consistent with this, in vivo studies found 14C label 
transferred from glycine to serine at twice the rate of 
serine to glycine [33]. Conversion of serine to glycine was 
not detected in isolated rabbit proximal tubules [2]. Other 
indirect evidence includes a more than two-fold faster ate 
of ammonia released when cortical slices were incubated 
with 10 mM glycine (21.0 /xmol.h -~ per g kidney) 
compared with 10 mM serine or no substrate (8.8 /zmol - 
h-1 per g kidney) [16]. Related evidence is that serine 
failed to protect proximal tubules against hypoxic injury 
[34], compared with glycine or glutathione [35]. If glycine 
was readily formed from serine, newly formed glycine 
should provide protection against hypoxic injury and the 
rate of ammonia formation should be similar when glycine 
or serine are single substrates. 
We also observed rapid formation of unlabelled glycine 
and serine at the start of the incubation. Fgly was consis- 
tently lower than the initial fraction of 13C-labelled glycine 
without significant change during further incubation (Ta- 
bles 1 and 2). Serine was less than 50% labelled, even with 
100% [2-~3C]glycine as sole substrate (Table 3). Multiple 
washes without glycine or serine during tubule preparation 
should have minimised the unlabelled glycine or serine 
present at the start of incubation. This has been demon- 
strated in rabbit proximal tubules where intracellular amino 
acids were washed out during preparation [2]. In addition, 
the very small intracellular volume of the tubules, com- 
pared to the volume of incubation medium, would require 
a very high intracellular unlabelled glycine concentration 
to alter the fraction of added labelled glycine from an 
initial concentration of 5 raM. Weinberg et al. [2] incu- 
bated purified rabbit proximal tubules with 2 mM [2- 
13C]glycine and unlabelled 5 mM glucose, 4.5 mM sodium 
lactate, 1 mM alanine, and 10 mM sodium butyrate for 15, 
30 and 60 min, and measured the ~3C-enrichment of serine 
as 30.6 ± 2.0, 42.4 _+ 2.1 and 47.3 _+ 3.8% respectively. 
The similarity of their results and ours obtained with 
glycine as the sole substrate (Table 3) suggests a source of 
unlabelled serine exists independent of the unlabelled sub- 
strates added. Studies on the contribution of proteolysis to 
glycine and serine formation have given conflicting results. 
G.J. Cowin et al. / Biochimica et Biophysica Acta 1310 (1996) 32-40 39 
Low rates of proteolysis, as indicated by amino acid 
release, have been reported in rabbit proximal tubules [2]. 
In contrast, serine formation from tubular protein in iso- 
lated rat cortical tubules, was estimated as 34.3 /~mol. g 
dry wt-1 per h, a value which could readily account for 
serine formation measured without added substrates (30 
/zmol • g dry wt- 1 per h) [29]. In the latter study, the rates 
of serine and glycine formation (30 and 8.2 /zmol • g dry 
wt-1 per h respectively) reported without added substrates 
[29], are sufficient o account for the decreased fraction of 
13C-labelled serine and glycine measured in this paper. The 
potential for de novo glyc!ine formation by the kidney has 
been demonstrated in normal rats by Lowry et al. [36], 
who observed that a net uptake of glycine of 208_ 83 
nmol • min- 1 per animal became anet release of 463 + 184 
nmol. min -~ per animal when animals were given cys- 
teamine to inhibit GC, suggesting that free glycine uptake 
accounted for less than 50% of available intracellular 
glycine. 
The ability to follow glycine incorporation i to m-THF, 
using F m and Fm~cC ), is unique to serine isotopomer analy- 
sis. This will allow potential precursors of m-THF to be 
added with glycine to assess their ability to compete with 
glycine as a source of the methyl group in m-THF. In this 
study, an initial Fg~y of 100%, 75% and 50% gave Fm~GC ) of 
99.0, 96.8 and 96.4% respectively (Table 2), suggesting 
that glycine was the major carbon donor for THF. This 
agrees with previous investigations of the stoichiometry of
serine formation in rat kidney cortical slices [16]. How- 
ever, as the incubation medium contained only free glycine 
and no other substrates, our study may have exaggerated 
the contribution of glycine as a methyl donor to THF. 
In conclusion, 13C-NMR detected rapid conversion of 
glycine to serine without significant formation of other 
products. Three unique serine isotopomers were detected 
by 13C-NMR, which confirmed the expected mitochondrial 
coupling of SHMT and GC in fresh rat renal proximal 
tubules and allowed the urdabelled fractions of glycine and 
m-THF to be predicted. The formation of serine from 
glycine by SHMT and GC was much faster than the 
reverse reaction. Serine i'sotopomer analysis and GC-MS 
provide an effective method for analysing the metabolic 
relationships between glycine and serine in situ and for 
detecting unlabelled glyciae, serine and m-THF formation 
under normal conditions and in disease states. 
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